Volume 16, Issue 4 (December 2024 2024)                   Iranian Journal of Blood and Cancer 2024, 16(4): 39-46 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Paronyan Z, Sahakyan I, Stepanyan H, Tumasyan N, Araqelyan L, Kocharyan N, et al . Effects of the Amino Acid Complex on Biochemical and Morphological Parameters of Hemostasis at Chronic Cadmium Intoxication. Iranian Journal of Blood and Cancer 2024; 16 (4) :39-46
URL: http://ijbc.ir/article-1-1578-en.html
1- H. Buniatian Institute of Biochemistry NAS Armenia.
2- H. Buniatian Institute of Biochemistry NAS Armenia. , nunekocharyan466@gmail.com
Abstract:   (438 Views)
Background: The present study was conducted to investigate the biochemical and morphological changes in the blood coagulation system caused by chronic cadmium intoxication and the anticoagulant activity of the amino acid complex (γ-aminobutyric acid, β-alanine, glutamine, ethanolamine-O-sulphate). Previous studies have investigated the effect of the amino acid complex (AAc) on blood glucose levels in animals with experimental alloxan diabetes. The use of this complex demonstrated the ability to suppress the hyperglycaemic effect of alloxan, while also exhibiting anticoagulant activity.
Materials and methods: The experiments were carried out on non-linear white male rats divided into 3 groups: control rats, rats receiving cadmium sulphate and rats with cadmium intoxication injected with AAc. Biochemical (recalcification, prothrombin time, international sensitivity index, thrombin time, activated partial thromboplastin time, fibrinogen level, calcium level) and histological (Haematoxylin & Eosin and Giemsa staining) methods were used in the studies.
Results and conclusion: Chronic cadmium intoxication leads to alterations in several blood coagulation parameters, suggesting a predisposition to hypercoagulation. However, administration of AAc reduces blood coagulation. Blood samples from poisoned rats showed the presence of red blood cells and leukocytes with morphological changes, including the presence of numerous platelets in clusters or groups. Conversely, when AAc was administered to cadmium poisoned rats, erythrocytes and neutrophils showed morphologically normal characteristics.  The results obtained confirm the anticoagulant activity of AAc, which may be used in the future for the treatment of various thrombotic conditions.
Full-Text [PDF 819 kb]   (197 Downloads)    
: Original Article | Subject: Pathology
Received: 2024/11/26 | Accepted: 2024/12/23 | Published: 2024/12/30

References
1. Ilyinov A.N., Ryazanov I.A., Osipov A.N. Acid erythrograms of mice poisoned with Zn, Cd and Pb. Toxicological Bulletin.1997; 14: 10-14.
2. Wang Bo, Yanli Du. Cadmium and Its Neurotoxic Effects. Oxid Med Cell Longev. 2013; 2013: 898034. [DOI:10.1155/2013/898034]
3. Charkiewicz A.E., Omeljaniuk W.J., Nowak K.K., Garley M., and Niklinski J. Cadmium Toxicity and Health Effects-A Brief Summary. Molecules. 2023; 28(18): 6620. [DOI:10.3390/molecules28186620]
4. Blainey JD, Adams RG, Brewer DB, Harvey TC. Cadmium-induced osteomalacia. Br J Ind Med. 1980; 37(3): 278-84. [DOI:10.1136/oem.37.3.278]
5. Fiévez L., Kirschvink N., Zhang W., Lagente V., Lekeux P., Bureau F., Gustin P. Effects of betamethasone on inflammation and emphysema induced by cadmium nebulisation in rats. Pulmonary, Gastrointestinal and Urogenital Pharmacology. 2009; 606(1-3): 210-214. [DOI:10.1016/j.ejphar.2009.01.020]
6. Gallagher CM, Meliker JR. Blood and urine cadmium, blood pressure, and hypertension: a systematic review and meta-analysis. Environ Health Perspect.2010;118 (12):1676-84. [DOI:10.1289/ehp.1002077]
7. Thévenod F. Nephrotoxicity and the Proximal Tubule: Insights from Cadmium Subject Area. Nephron Physiology.2003; 93(4): 87-93.. [DOI:10.1159/000070241]
8. Helmestam M., Stavreus-Evers A., Olovsson M. Cadmium chloride alters mRNA levels of angiogenesis related genes in primary human endometrial endothelial cells grown in vitro. Reprod.Toxicol. 2010; 30(3): 370-376.doi: 10.1016/j.reprotox.2010.05.003. [DOI:10.1016/j.reprotox.2010.05.003]
9. Waalkes MP, Rehm S. Cadmium and prostate cancer. J Toxicol Environ Health. 1994 Nov; 43(3):251-69. [DOI:10.1080/15287399409531920]
10. Prozialek WC, Edwards JR, Woods JM. The vascular endothelium as a target of cadmium toxicity. Life Sci. 2006; 79: 1493-1506. [DOI:10.1016/j.lfs.2006.05.007]
11. Wang X. et al. Low doze cadmium upregulates the expression of von Willebrand factor in endothelial cells. Toxicol. Lett. 2018; 290: 46-54. [DOI:10.1016/j.toxlet.2018.03.020]
12. Kokame K, Sakata T, Kokiwo Y, Miyata T. von Willebrand factor-to. ADAMTS13 ratio increases with age in a Japanese population. J.Thromb. Haemost. 2011; 9: 1426-1428. [DOI:10.1111/j.1538-7836.2011.04333.x]
13. Hasimoto Y, et al. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity. Thromb. Res. 1987; 46: 625-633. [DOI:10.1016/0049-3848(87)90264-7]
14. Samoilov M.V., Naumov A.G. Morphofunctional characteristics of erythrocytes as a criterion of the severity of endogenous intoxication. Russian medical journal. 2000; 1: 31-33.
15. Suwalsky M. , Villena F., Norris B., Cuevas F., Sotomayor C․ Cadmium-induced changes in the membrane of human erythrocytes and molecular models․ J Inorg Biochem, 2004; 98(6): 1061-6. DOI: [DOI:10.1016/j.jinorgbio.2004.02.027]
16. Verbost P.M., Flik G., Pang P.K., Lock R.A., Wendelaar Bonga S.E. Cadmium inhibition of the erythrocyte Ca2+ pump. Jour. Biol. Chem. 1989; 264: 5613. [DOI:10.1016/S0021-9258(18)83591-8]
17. Paronyan, Z. Kh., Khachatryan R. S., Stepanyan A. A., Grigoryan L. S., Arakelyan L. N. Changes in glucose levels and some blood coagulation parameters in rats with experimental alloxan-induced diabetes under the influence of a new amino acid complex. Medical Science of Armenia. NAS RA; 2021: 61(3): 64-72.
18. Paronyan Z.Kh.,Araqelyan L.N., Grigoryan L.S., Khachatryan R.S., Galstyan A.Z., Stepanyan A.A. The influence of an antidiabetic amino acid complex on some parameters of plasma hemostasis. Medical Science of Armenia. 2023; 63(3): 64-71. doi:10.54503/0514-7484-2023-63.3-64. [DOI:10.54503/0514-7484-2023-63.3-64]
19. Edigarova L.V., Akopyan V.G. Antiplatelet activity of the vascular wall and the possibility of its correction with GABAergic agents in conditions of hypokinesia. Experimental and clinical pharmacology, 2000. 5, p. 41 - 43.
20. Fischer A, Jacobson KA, Rose J and Zeller R: Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc pdb.prot4986, 2008. [DOI:10.1101/pdb.prot4986]
21. Redginal H: Giemsa preparation for staining blood films. Science 86: 548, 1937. [DOI:10.1126/science.86.2241.548]
22. Zubairov D.M. Coagulation disorders due to vitamin K deficiency and indirect anticoagulants. KAZAN MEDICAL JOURNAL. 1995; 76(4):344-346. doi: https://doi.org/10.17816/kazmj105001 [DOI:10.17816/kazmj105001.]
23. Beth H.Shar MD, Christofer D. Hillyer MD. Cryoprecipitate and Fibrinogen Concentrates Transfusion Medicine and Hemostasis (Second Edition). 2013.
24. Barbier O, Iacqullet G.,Taic M. et al. Acute study of interaction between cadmium, calcium and zinc transport along the rat nephron in vivo, Am. I.Physiol. Renal. Physiol. 2004; 287:1067-1075. [DOI:10.1152/ajprenal.00120.2004]
25. Kranias E.G., Bers D.M. Calcium and cardiomyopathies, Subcell. Biochem. 2007; 45: 523-537. [DOI:10.1007/978-1-4020-6191-2_20]
26. Chandrasekar Palaniswamy MD, Arunabh Sekhri MD, Wilbert S. Aronow MD, Ankur Kalra MD, Stephen J. Peterson MD, MACP. Association of Warfarin Use With Valvular and Vascular Calcification: A Review. Clinical Cardiology. 2011;34(2): 74-81. [DOI:10.1002/clc.20865]
27. Shea M.K., Cushman, S.L. Booth, G.L. Burke and HCSB Krichevsky, Vitamin K status and vascular calcification: evidence from observational and clinical studies. Advances in Nutrition. 2012; 3(2): 158-165. [DOI:10.3945/an.111.001644]
28. Krüger T., Westenfeld R., Schurgers L., Vincent M. Brandenburg. Coagulation Meets Calcification: The Vitamin K System. The International journal of artificial organs. 2009; 32(2): 67-74. [DOI:10.1177/039139880903200202]
29. Prorialeck WC, Edwards JR, Woods JM. The vascular endothelium as a target of cadmium toxicity. Life Sci. 2006; 79: 1493-1506. [DOI:10.1016/j.lfs.2006.05.007]
30. Wang X, et al. Low doze cadmium upregulates the expression if von Willebrand factor in endothelial cells. Toxicol. Lett. 2018; 290: 46-54. [DOI:10.1016/j.toxlet.2018.03.020]
31. Albanes S. et al. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms. J. Thromb. Haemost. 2016; 14: 953- 963. [DOI:10.1111/jth.13294]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb